Back to Search
CHRISTOPHER NG, MD
MD
Emergency Medicine Physician
NPI: 1790711588IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
G58520(CA)
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
G58520(CA)
Education
UNIVERSITY OF SOUTHERN CALIFORNIA KECK SCHOOL OF MEDICINE
Class of 1985
Research & Publications (20)
Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice.
PMID 17446441·Arterioscler Thromb Vasc Biol·2007
7-preclinical
Adenovirus mediated expression of human paraoxonase 2 protects against the development of atherosclerosis in apolipoprotein E-deficient mice.
PMID 16935014·Mol Genet Metab·2006
7-preclinical
Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2.
PMID 16891303·J Biol Chem·2006
7-preclinical
A new challenge for successful immunotherapy by tumors that are resistant to apoptosis: two complementary signals to overcome cross-resistance.
PMID 12374285·Adv Cancer Res·2002
6-review
Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
PMID 12430140·Prostate·2002
8-other
X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO).
PMID 12481428·Mol Cancer Ther·2002
8-other
Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein.
PMID 11579088·J Biol Chem·2001
8-other
Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-α5β1 integrin monoclonal antibody (volociximab) in cancer patients.
PMID 19468731·Cancer Chemother Pharmacol·2010
3-trial
A comparison of postoperative complications in open versus robotic cystectomy.
PMID 19560255·Eur Urol·2010
4-observational
Mating system and seed variation of Acacia hybrid (A. mangium x A. auriculiformis).
PMID 19417541·J Genet·2009
8-other
Self-retaining pledgeted suture as retractor for mitral procedure.
PMID 19592559·Asian Cardiovasc Thorac Ann·2009
8-other
Conformational flexibility and molecular interactions of an archaeal homologue of the Shwachman-Bodian-Diamond syndrome protein.
PMID 19454024·BMC Struct Biol·2009
7-preclinical
Ventilation during cardiopulmonary bypass: impact on cytokine response and cardiopulmonary function.
PMID 18154801·Ann Thorac Surg·2008
2-rct
Minimal-preparation abdomino-pelvic CT in frail and elderly patients: prognostic value of colonic and extracolonic findings.
PMID 18325363·Clin Radiol·2008
8-other
Sex combs are important for male mating success in Drosophila melanogaster.
PMID 18213513·Behav Genet·2008
7-preclinical
Assessing diagnostic confidence: a comparative review of analytical methods.
PMID 18423315·Acad Radiol·2008
6-review
Chemical amplification in an invaded food web: seasonality and ontogeny in a high-biomass, low-diversity ecosystem.
PMID 18544008·Environ Toxicol Chem·2008
7-preclinical
Factors influencing parental decision to consult for children with upper respiratory tract infection.
PMID 17999669·J Paediatr Child Health·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1300 N VERMONT AVE
LOS ANGELES, CA 90027 - Phone
- (323) 916-4892
Quick Facts
- NPI
- 1790711588
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 41
- Publications
- 20
Are you this provider?
Claim Your Profile